Why Bill Ackman Makes Valeant Pharmaceuticals Intl Inc. Shareholders Nervous

Pershing Square may have to sell shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), driving the shares down further.

| More on:
The Motley Fool

During a lengthy conference call back in November, Pershing Square hedge fund manager Bill Ackman laid out his bull case for Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), infamously stating, “The biggest regret I have with Valeant is that we’re not in a position to buy more.” I’m sure by now he wishes he could take that quote back.

Making matters worse for Mr. Ackman, his losses could put further downward pressure on Valeant’s share price. We’ll take a closer look below.

Pershing’s losses

Mr. Ackman would have bought more Valeant when he made that call, if only he had the capital to spare. But he did find a cheaper way to bet on the company: options.

To be more specific, Mr. Ackman made two very large option trades in late November, buying calls and selling puts in each of them. One of those trades has since expired, but Mr. Ackman is still on the hook for over nine million put options that expire in early 2017 (according to Pershing’s most recent filings).

Those puts have a strike price of US$60, meaning that as of this writing, those puts are now over US$200 million in the hole. On top of that, Pershing lost about US$700 million on its Valeant shares on Monday, and its call options will most likely expire worthless.

What this means for Valeant’s shares

The fall in Valeant’s shares will undoubtedly trigger a margin call on the Valeant put options, forcing Pershing to come up with the cash. This may force Pershing to sell stocks.

If investors decide to flee Pershing, then the fund could be forced to sell even more stocks, including Valeant’s. Of course, this would cause fund performance to deteriorate, causing more investors to flee, and so the cycle goes. It’s no coincidence that Herbalife Ltd. shares increased on Monday; investors are betting that Valeant will be under a lot of pressure.

Pershing is not alone

Valeant is commonly referred to as a “hedge fund hotel,” meaning that a lot of hedge funds own the shares. And these funds usually hold very concentrated positions. For example, Valeant represented 32% of the Sequoia Fund’s portfolio back in August.

Thus we could easily see some big forced sales in Valeant’s shares, which would drive the stock down further. If you own any shares, watch out.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Benjamin Sinclair has no position in any stocks mentioned.  Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

Nuclear power station cooling tower
Energy Stocks

Why Shares of Cameco Are Powering Higher

Cameco (TSX:CCO) shares have surged more than 400% in the last five years alone, with more growth on the way.

Read more »

A bull outlined against a field
Stocks for Beginners

Bull Market Buys: 2 TSX Stocks to Own for the Long Run

Are you looking for stocks that could see a bull run for decades ahead? Here are two top TSX stocks…

Read more »

financial freedom sign
Dividend Stocks

Million-Dollar TFSA: 1 Way to Achieve to 7-Figure Wealth

Achieving seven-figure TFSA wealth is doable with two large-cap, high-yield dividend stocks.

Read more »

analyze data
Dividend Stocks

How Much Will Manulife Financial Pay in Dividends This Year?

Manulife stock's dividend should be safe and the stock appears to be fairly valued.

Read more »

food restaurants
Dividend Stocks

Better Stock to Buy Now: Tim Hortons or Starbucks?

Starbucks and Restaurant Brands International are two blue-chip dividend stocks that trade at a discount to consensus price targets.

Read more »

Diggers and trucks in a coal mine
Metals and Mining Stocks

1 Canadian Mining Stock Worth a Long-Term Investment

Cameco (TSX:CCO) stock could be a great long-term investment for Canadian growth seekers.

Read more »

Pot stocks are a riskier investment

Could Investing $10,000 in Aurora Cannabis Stock Make You a Millionaire?

Let's dive into whether Aurora Cannabis (TSX:ACB) could be a potential millionaire-maker stock, or a dud, over the long term.

Read more »

stock analysis
Energy Stocks

Is Enbridge Stock a Good Buy in May 2024?

Boasting high-yielding dividends and a stable underlying business, Enbridge (TSX:ENB) might be a great buy for your self-directed investment portfolio…

Read more »